{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:51:59Z","timestamp":1788241919215,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of healthcare-associated infections in Europe. It has become increasingly prevalent in community settings, causing skin and soft tissue infections (SSTIs). Managing community-acquired (CA) MRSA infections is challenging due to its high virulence and resistance to common antibiotics, and prevention outside the hospital setting is complex. Combination therapy has demonstrated efficacy in the treatment of severe MRSA infections. Furthermore, surgical source control is critical in treating CA-MRSA infections, involving removing the primary infection site to interrupt bacterial replication. Timeliness and a correct surgical approach are essential for successful treatment outcomes and improved quality of life. Methods: This report details the case of a 15-year-old athlete who was admitted to the intensive care unit with septic shock caused by CA-MRSA. Results: Despite initial treatment, his condition rapidly worsened. A computed tomography (CT) scan identified multiple abscesses (in the lungs, limbs, thyroid, and subscapular region) along with other complications. To achieve adequate tissue concentrations at all affected sites, a triple-targeted antimicrobial therapy was initiated and adjusted based on therapeutic drug monitoring (TDM). At the same time, daily surgical debridement was performed. The patient responded significantly to this treatment, and blood cultures eventually returned negative. Conclusions: A multidisciplinary approach involving early source control, tailored antimicrobial therapy, and, if monotherapy fails to control infection, combination therapy is advisable to treat life-threatening CA-MRSA infections.<\/jats:p>","DOI":"10.3390\/idr17020027","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T06:21:38Z","timestamp":1742797298000},"page":"27","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effective Management of a Skin and Soft Tissue Infection Caused by Community-Acquired MRSA Through Triple-Targeted Therapy Along with Aggressive Source Control: A Case Report"],"prefix":"10.3390","volume":"17","author":[{"given":"Matteo","family":"Laratta","sequence":"first","affiliation":[{"name":"Department of Anaesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9765-5529","authenticated-orcid":false,"given":"Stefano","family":"Agliardi","sequence":"additional","affiliation":[{"name":"Postgraduate School of Clinical Pharmacology and Toxicology, Department of Medical Biotechnology and Translational Medicine, University of Milan, 20122 Milan, Italy"},{"name":"Chemical-Clinical Analyses Unit, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1091-110X","authenticated-orcid":false,"given":"Matteo","family":"Sola","sequence":"additional","affiliation":[{"name":"Post-Graduate School of Anesthesia, Intensive Care and Pain Medicine, School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3210-1714","authenticated-orcid":false,"given":"Stefano","family":"Spina","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Fumagalli","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy"},{"name":"Post-Graduate School of Anesthesia, Intensive Care and Pain Medicine, School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"ref_1","unstructured":"European Centre for Disease Prevention and Control (2023). Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report 2022, European Centre for Disease Prevention and Control (ECDC)."},{"key":"ref_2","unstructured":"European Centre for Disease Prevention and Control, and World Health Organization (2022). Antimicrobial Resistance Surveillance in Europe 2022: 2020 Data, Publications Office."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3201\/eid1212.060505","article-title":"Community-Associated Methicillin-Resistant Staphylococcus aureus and Healthcare Risk Factors","volume":"12","author":"Klevens","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cmi.2024.06.006","article-title":"Community Methicillin-Resistant Staphylococcus aureus Outbreaks in Areas of Low Prevalence","volume":"31","author":"Bellis","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of Resistance: Staphylococcus aureus in the Antibiotic Era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gatti, M., Viaggi, B., Rossolini, G.M., Pea, F., and Viale, P. (2023). Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence. Microorganisms, 11.","DOI":"10.3390\/microorganisms11020394"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/cid\/ciab452","article-title":"Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does It Work, Which Combination, and For Which Patients?","volume":"73","author":"Rose","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining Persistent Staphylococcus aureus Bacteraemia: Secondary Analysis of a Prospective Cohort Study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00006454-200408000-00025","article-title":"Treatment of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections With Drainage But No Antibiotic Therapy","volume":"23","author":"Miller","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"De Marco, G., Vazquez, O., Gavira, N., Ramadani, A., Steiger, C., Dayer, R., and Ceroni, D. (2022). Surgery\u2019s Role in Contemporary Osteoarticular Infection Management. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.1043251"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciz257","article-title":"Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes","volume":"70","author":"Minejima","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jgar.2020.12.009","article-title":"Meta-Analysis of Vancomycin versus Linezolid in Pneumonia with Proven Methicillin-Resistant Staphylococcus aureus","volume":"24","author":"Kato","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.12998\/wjcc.v10.i8.2550","article-title":"Daptomycin and Linezolid for Severe Methicillin-Resistant Staphylococcus aureus Psoas Abscess and Bacteremia: A Case Report and Review of the Literature","volume":"10","author":"Hong","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2147\/TCRM.S75412","article-title":"Ceftaroline in the Management of Complicated Skin and Soft Tissue Infections and Community Acquired Pneumonia","volume":"11","author":"Mpenge","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eimc.2019.03.007","article-title":"Actividad in vitro de la combinaci\u00f3n de ceftarolina con otros antimicrobianos activos frente a Staphylococcus spp.","volume":"38","year":"2020","journal-title":"Enfermedades Infecc. Microbiol. Cl\u00ednica"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-016-1551-7","article-title":"Effects of Continuous Renal Replacement Therapy on Linezolid Pharmacokinetic\/Pharmacodynamics: A Systematic Review","volume":"20","author":"Villa","year":"2016","journal-title":"Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Corona, A., Veronese, A., Santini, S., and Cattaneo, D. (2022). \u201cCATCH\u201d Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study. Antibiotics, 11.","DOI":"10.3390\/antibiotics11121811"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lin, B., Hu, Y., Xu, P., Xu, T., Chen, C., He, L., Zhou, M., Chen, Z., Zhang, C., and Yu, X. (2022). Expert Consensus Statement on Therapeutic Drug Monitoring and Individualization of Linezolid. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.967311"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-022-04050-9","article-title":"Expert Clinical Pharmacological Advice May Make an Antimicrobial TDM Program for Emerging Candidates More Clinically Useful in Tailoring Therapy of Critically Ill Patients","volume":"26","author":"Gatti","year":"2022","journal-title":"Crit. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkac380","article-title":"In Vitro Activity of Fosfomycin Alone and in Combination against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin or Linezolid","volume":"78","author":"Saravolatz","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Finazzi, S., Luci, G., Olivieri, C., Langer, M., Mandelli, G., Corona, A., Viaggi, B., and Di Paolo, A. (2022). Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review\u2014Part I. Antibiotics, 11.","DOI":"10.3390\/antibiotics11091164"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dijkmans, A.C., Zacar\u00edas, N.V.O., Burggraaf, J., Mouton, J.W., Wilms, E., Van Nieuwkoop, C., Touw, D.J., Stevens, J., and Kamerling, I.M.C. (2017). Fosfomycin: Pharmacological, Clinical and Future Perspectives. Antibiotics, 6.","DOI":"10.3390\/antibiotics6040024"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical Management of Staphylococcus aureus Bacteremia: A Review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciac364","article-title":"Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management","volume":"75","author":"Holland","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamasurg.2022.2761","article-title":"Association Between Time to Source Control in Sepsis and 90-Day Mortality","volume":"157","author":"Reitz","year":"2022","journal-title":"JAMA Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-016-1211-y","article-title":"Feasibility and Safety of Low-Flow Extracorporeal Carbon Dioxide Removal to Facilitate Ultra-Protective Ventilation in Patients with Moderate Acute Respiratory Distress Syndrome","volume":"20","author":"Fanelli","year":"2016","journal-title":"Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00134-019-05567-4","article-title":"The \u201cStrategy of Ultra-Protective lung ventilation with Extracorporeal CO2 Removal for New-Onset moderate to severe ARDS\u201d (SUPERNOVA) investigators. Feasibility and Safety of Extracorporeal CO2 Removal to Enhance Protective Ventilation in Acute Respiratory Distress Syndrome: The SUPERNOVA Study","volume":"45","author":"Combes","year":"2019","journal-title":"Intensive Care Med."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/2\/27\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:59:06Z","timestamp":1760029146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/2\/27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["idr17020027"],"URL":"https:\/\/doi.org\/10.3390\/idr17020027","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]}}}